help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taurog, A.
Right arrow Articles by Dorris, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taurog, A.
Right arrow Articles by Dorris, M. L.

Endocrinology, Vol 124, 3038-3042, Copyright © 1989 by Endocrine Society


ARTICLES

A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil

A Taurog and ML Dorris
Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75235.

The antithyroid drug 6-propylthiouracil (PTU) was previously shown in our laboratory to have an unexpectedly prolonged inhibitory effect on iodination in the thyroid glands of rats. Eighteen hours after injection of a relatively small dose, iodination in the thyroid remained inhibited by more than 90%. We previously suggested that the prolonged inhibitory effect might be due to inactivation of thyroid peroxidase (TPO), a reaction previously shown to occur under certain conditions in an in vitro iodinating system containing highly purified TPO. However, the analytical procedure used in our earlier study did not exclude the possibility that sufficient PTU remained in the thyroid even after 18 h to inhibit TPO-catalyzed iodination by a reversible mechanism. Development of an improved analytical procedure, based on HPLC, led us to reexamine the mechanism of the prolonged inhibitory effect of PTU on iodination in rat thyroid glands. Rats were injected with [35S]PTU (1 mumol/100 g BW), and ultrafiltrates prepared from their homogenized thyroid glands were analyzed by HPLC. The major 35S- labeled metabolites were identified as sulfate/sulfite, PTU sulfinate, and PTU sulfonate. However, even after 18 h, a significant amount of unchanged [35S]PTU was also present. The calculated mean concentration of residual PTU was 20 microM, a sufficiently high level to explain the observed inhibition of iodination on the basis of a reversible mechanism. Experiments were also performed to examine the intrathyroidal distribution of 35S at intervals after the injection of [35S]PTU. All of the oxidation products of PTU showed marked increases between 2 and 16 h after injection. Based on our view that TPO is the major mediator of intrathyroidal metabolism of PTU, this observation is inconsistent with our previous proposal that TPO is inactivated after PTU injection. The results of the present study, therefore, lead us to withdraw our previous suggestion that TPO is inactivated after injection of PTU into rats. It is more likely that inhibition of iodination by PTU in the rat thyroid involves competition between PTU and tyrosyl residues of thyroglobulin for oxidized iodine, comparable to the reversible mechanism of inhibition observed in the TPO model system.


This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Schmutzler, A. Bacinski, I. Gotthardt, K. Huhne, P. Ambrugger, H. Klammer, C. Schlecht, C. Hoang-Vu, A. Gruters, W. Wuttke, et al.
The Ultraviolet Filter Benzophenone 2 Interferes with the Thyroid Hormone Axis in Rats and Is a Potent in Vitro Inhibitor of Human Recombinant Thyroid Peroxidase
Endocrinology, June 1, 2007; 148(6): 2835 - 2844.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Fujimoto, H. Onodera, K. Mitsumori, T. Tamura, S. Maruyama, and A. Ito
Changes in thyroid function during development of thyroid hyperplasia induced by kojic acid in F344 rats
Carcinogenesis, August 1, 1999; 20(8): 1567 - 1572.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Mitsumori, H. Onodera, M. Takahashi, T. Funakoshi, T. Tamura, K. Yasuhara, K. Takegawa, and M. Takahashi
Promoting effects of kojic acid due to serum TSH elevation resulting from reduced serum thyroid hormone levels on development of thyroid proliferative lesions in rats initiated with N-bis(2-hydroxypropyl)nitrosamine
Carcinogenesis, January 1, 1999; 20(1): 173 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. D. Ross, I. Dey, N. Janes, and Y. Israel
Effect of Antithyroid Drugs on Hydroxyl Radical Formation and alpha -1-Proteinase Inhibitor Inactivation by Neutrophils: Therapeutic Implications
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1233 - 1238.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society